Workflow
OTC Markets Group Welcomes DIRTT Environmental Solutions Ltd to OTCQX
Globenewswire· 2025-06-11 11:00
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced DIRTT Environmental Solutions Ltd (TSX: DRT; OTCQX: DRTTF), a leader in industrialized construction, has qualified to trade on the OTCQX® Best Market. DIRTT Environmental Solutions Ltd upgraded to OTCQX from the Pink® market. DIRTT Environmental Solutions Ltd begins trading today on OTCQX under the symbol “DRTTF.” U.S. investors ...
Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs
Prnewswire· 2025-06-11 11:00
SAN DIEGO and CALGARY, AB, June 11, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the appointment of Jared Kelly as Chief Executive Officer and a member of its Board of Directors.Mr. Kelly is a successful biotech executive who has proven expertise in transformative deals and corporate strategy. Most recently, he played a central role in orchestrating the sale of Ambrx Biopharma to Johnson ...
Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial
Prnewswire· 2025-06-11 11:00
Both vaccine candidates induced robust immune responses across all antigens tested No new safety signals were observed and both vaccine candidates were well tolerated consistent with past trials Novavax continues to pursue partnering opportunities to advance further development of these programs GAITHERSBURG, Md., June 11, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent hemagglutinin nanopa ...
Iterum Therapeutics Announces Partnership for Commercialization Services
Globenewswire· 2025-06-11 11:00
U.S. Commercial Launch of ORLYNVAHTM by Q4 2025; First Oral Penem Available in the U.S. Management to host a conference call at 4:30 p.m. ET today DUBLIN and CHICAGO, June 11, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported that it entered into a Product Commercialization Agree ...
NVIDIA Partners With Novo Nordisk and DCAI to Advance Drug Discovery
Globenewswire· 2025-06-11 10:52
Leading Global Pharma Joins Danish Enterprises, Startups and Public Health Systems Using AI Factories to Improve Drug Discovery and Healthcare Novo Nordisk / DCAI NVIDIA is collaborating with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases. PARIS, June 11, 2025 (GLOBE NEWSWIRE) -- NVIDIA GTC Paris at VivaTech — NVIDIA today announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases. The work supports Novo Nordisk’s ag ...
Nvidia makes big play for Europe with infrastructure deals
CNBC· 2025-06-11 10:49
Jensen Huang, co-founder and CEO of Nvidia Corp., speaks during a news conference in Taipei on May 21, 2025. Cheng / AFP) (Photo by I-HWA CHENG/AFP via Getty Images)Nvidia on Wednesday announced a slew of partnerships with European countries and companies spanning infrastructure to software as it looks to keep itself at the center of the global artificial intelligence story.Chief Executive Jensen Huang on Wednesday continued his tour of Europe with a keynote at Nvidia's GTC event in Paris, France, where he ...
JPMorgan CEO: ‘Real Chance' US Economic Numbers Will Dip
PYMNTS.com· 2025-06-11 10:42
The head of America’s largest bank has a gloomy forecast for the U.S. economy.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.“I think there’s a real chance numbers will deteriorate soon,” J.P. Morgan Chase CEO Jam ...
Markel Group: A Magnifying Glass On Ventures
Seeking Alpha· 2025-06-11 10:41
I have covered Markel Group (NYSE: MKL ) as a Strong Buy since early this year. 2025 will be an interesting year for us shareholders as the company is undergoing a strategic review (discussed here ) sponsored by activist JANA Partners.Striving to compound knowledge. Long-time fan of Warren and Charlie. Always invert. "To finish first, you must first finish". Investing own and family funds for +20 years. Senior finance roles at public and private corporations for most of that time.Analyst’s Disclosure:I/we h ...
Taseko Mines: Putting Another Catalyst On The Board
Seeking Alpha· 2025-06-11 10:40
Taseko Mines Limited (NYSE: TGB ) (TSX: TKO:CA ) is a small-cap copper producer, based in British Columbia and Arizona. Its flagship producing asset is its Gibraltar mine in BC, but its near-term Florence Copper project in Arizona will be a trueI am interested in small capitalized companies with a high optionality to the upside compared to the relative downside risk. I am grounded in a value based approach but will also explore special and short situations. I am a trained CPA and continue to practice in ind ...
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month
GlobeNewswire· 2025-06-11 10:30
Core Insights - Teleflex Incorporated has launched two initiatives to raise awareness about benign prostatic hyperplasia (BPH) during Men's Health Month, focusing on quality-of-life issues and potential rectal toxicity from prostate cancer radiation treatment [3][8]. Group 1: Awareness Initiatives - The initiatives include the "Prostate Monster" ad campaign and the Prostate Education Express, a mobile training center that will tour major U.S. cities throughout 2025 [4][5]. - The Prostate Education Express aims to educate both physicians and the community about BPH and the benefits of the UroLift™ System and Barrigel™ rectal spacer [4][7]. Group 2: UroLift™ System - The UroLift™ System is a minimally invasive treatment for BPH symptoms, indicated for men aged 45 and older, and has been used to treat over 500,000 men globally [10][6]. - A clinical study showed a low retreatment rate of about 2-3% per year, indicating the durability of the UroLift™ System [10]. Group 3: Barrigel™ Rectal Spacer - Barrigel™ rectal spacer is the first hyaluronic acid rectal spacer designed to protect the rectum during radiation therapy for prostate cancer, with over 50,000 men treated [12][8]. - A clinical study found that 98.5% of men treated with Barrigel™ achieved at least a 25% reduction in radiation to the rectum, with an average reduction of 85% [8].